A phase 1 study of the combination chemotherapy of sorafenib with cisplatin transcatheter arterial infusion for advanced hepatocellular carcinoma.
Phase of Trial: Phase I
Latest Information Update: 12 May 2016
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin
- Indications Liver cancer
- Focus Adverse reactions
- 22 Jan 2014 Status changed from active, no longer recruiting to completed, as reported by University Hospital Medical Information Network - Japan record.
- 14 Dec 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 02 Dec 2008 New trial record.